The Valley Desk

ReviewBiomoleculesPublished

Targeting the WNT/β-Catenin Pathway in Hematological Malignancies: From Molecular Pathogenesis to Emerging Therapeutic Strategies

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, Temple Health. Affiliation source

Publication record

Type
Review
Venue
Biomolecules
Published
Subject terms
Animals; Humans; Hematologic Neoplasms; Antineoplastic Agents; beta Catenin; Molecular Targeted Therapy; Wnt Signaling Pathway; Hematological malignancies; Combination therapy; Targeted Therapy; Wnt/β-catenin Signaling
PubMed ID
42194003
PubMed Central ID
PMC13204059
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal